General AML

Prof. Farhad Ravandi | ASH 2017 | Nivolumab with cytarabine & idarubicin in newly diagnosed AML

L:

59th  ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA